Info

home SymbolENOV

Exchange: NYSE·Updated 02:11 PM EDT

ENOV Enovis Corp

$18.59

$0.82

(4.62%)

Today

EarningsNov 4

Mkt Cap$1.02B

Vol391,541.00

About ENOV

Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.

Fundamentals

Mkt Cap

$1.02B

52W High

$34.28

52W Low

$17.30

PE Ratio

-0.92

Avg. Volume

2.24M

EPS (Annual)

-$20.72

Rev/Employee

$288,137.53

Earnings

Nov 04

Bearish Sentiment

How do you feel about ENOV?

Inphatec

Sep 8

$ENOV They discussed how geographically, they’re just starting to tap into additional markets and latest acquisitions allows them to innovate on various other fronts that will improve the top line in the coming years. They had multiple audits prior to buying out their latest company. It’s a positive in their eyes after a series of tests and checks.